 | |
     |
  |
 | ||
|
|
Intellectual Property |
|
 | ||
| Intellectual Property | ||
| |
||
| Intellectual Property |
||
| Developing
an IP Portfolio in an Emerging Biotechnology Company Keith Daellenbach, Bioject |
 3.4MB |
|
| Patent
Strategy Chris Tuttle, Alleman Hall McCoy Russell & Tuttle |
600K |
|
Investing
in Innovation through Acquisition |
85K |
|
| Financing
Technology Transfer Opportunities Brock Metcalf - Managing Partner, Cascadia Partners |
260K |
|
| Technology
Transfer - Avoiding the "Red Tape" Arundeep S. Pradhan - Director, Technology and Research Collaborations, Oregon Health & Science University (OHSU) |
100K |
|
| Commercializing
the Patents of Sharp Laboratories of America Jon Clemens - President, Sharp Technology Ventures |
65K |
|
| Structuring
Licensing Agreements to Avoid Downstream Problems Scott Davidson - Partner, White & Lee LLP |
2004 Session |
|
| Using
IP Strategy to Block the Competition...and Enter New Markets Dennis Fernandez |
SFF 2003 Session 2 |
|
| IP
Strategies - Protecting Intellectual Property Steve Weinberg |
||
| Impact of Government
Changes |
||
| New
Government Regulations That Impact EDA & IP Larry Disenhof, Cadence Design Systems, Inc |
Speaker 1 |
|
| Sarbanes
Oxley for Pre-Public Companies - Why You Should Care Katy Yeager, Horn Murdock Cole |
Speaker 2 |
|
| IRC
409A Option Pricing Rules That You Need to Know Kent Graham, Ernst & Young |
Speaker 3 |
|
| Corporate
Controls That Strengthen Performance John Macauley, Fox Technologies |
Speaker 4 |
|
Home | Firm Profile | Publications | Attorney Profiles News & Events | Links | Contact |
|